Value of neutrophil CD64 index in the etiological diagnosis of community-acquired pneumonia in children

Value of neutrophil CD64 index in the etiological diagnosis of community-acquired pneumonia in children

Objective To investigate the value of neutrophil CD64 (nCD64) index in the etiological diagnosis of community acquired pneumonia (CAP) in children. Methods A total of 108 children with CAP who were hospitalized in our hospital from November 2018 to July 2019 were enrolled, and according to etiology...

Full description

Saved in:

Bibliographic Details
Main Author:	XU Lei, LIU Xiaomeng, SUN Caihong, ZHANG Mengxue, QU Zhenghai
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Precision Medicine 2025-02-01
Series:	精准医学杂志
Subjects:	neutrophils\|community-acquired infections\|pneumonia, bacterial\|sensitivity and specificity\|child
Online Access:	https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/1744957590201-1089539551.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Etiological Structure of Community-Acquired Pneumonia in the period of COVID-19 epidemic
by: V. I. Sergevnin, et al.
Published: (2024-03-01)

The clinical usefulness of neutrophil percentage/albumin ratio in predicting the one-month mortality in chronic obstructive pulmonary disease patients hospitalized with community-acquired pneumonia
by: Sule Gul, et al.
Published: (2025-06-01)

Clinical and Etiological Features of Community-acquired Pneumonia in Children in Vladivostok
by: L. G. Erokhina, et al.
Published: (2015-12-01)

Can clinical findings at admission allow withholding of antibiotics in patients hospitalized for community acquired pneumonia when a test for a respiratory virus is positive?
by: Ryan Ward, et al.
Published: (2025-01-01)

The role of the neutrophil-to-lymphocyte ratio in predicting outcomes among patients with community-acquired pneumonia
by: Yogesh Sharma, et al.
Published: (2025-01-01)

Novelties in the treatment of community-acquired and hospital-acquired pneumonia
by: Matteo Bassetti, et al.
Published: (2025-04-01)

Community-acquired pneumonia: risk factors, prognosis, microbial etiology, treatment, and prophylaxis
by: Catia Cilloniz, et al.
Published: (2025-04-01)

Community-Acquired Pneumonia of Bacterial Etiology and the Spectrum of Pathogen Sensitivity to Antibiotics in Corona-Positive and Corona-Negative Patients in Rostov-on-Don
by: N. V. Pavlovich, et al.
Published: (2021-05-01)

Impact of infectious etiology on the outcome of Taiwanese patients hospitalized with community acquired pneumonia
by: Yuan-Ti Lee, et al.
Published: (2013-02-01)

Comparing viral, bacterial, and coinfections in community-acquired pneumonia, a retrospective cohort study
by: Frederike Waldeck, et al.
Published: (2025-05-01)

The Burden of Hospitalization and Rehospitalization Among Patients Hospitalized with Severe Community-Acquired Bacterial Pneumonia in the United States, 2018–2022
by: Marya D. Zilberberg, et al.
Published: (2025-06-01)

The improved prediction value of neutrophil to lymphocyte ratio to pneumonia severity scores for mortality in the older people with community-acquired pneumonia
by: Lixue Huang, et al.
Published: (2025-07-01)

Advanced biomarkers for prognostic evaluation of pneumonia severity in pediatric intensive care: focus on novel inflammatory and hematological ratios
by: Murat Ari, et al.
Published: (2025-06-01)

Hospital-acquired pneumonia: risk factors and prognosis, microbial etiology, treatment, and prophylaxis
by: Davide Calabretta, et al.
Published: (2025-04-01)

Features of laboratory indicators of severe community-acquired pneumonia.
by: T. A. Pertzeva, et al.
Published: (2017-06-01)

Тhe features of severe community acquired pneumonia
by: Avramenko I.V.
Published: (2015-06-01)

Modern characteristics of publicly acquired pneumonia caused by Clamydophyla pneumoniae
by: A. I. Danilov, et al.
Published: (2021-06-01)

Neutrophil-to-lymphocyte ratio in predicting prognosis and course of community community-acquired pneumonia in hospitalized patients.
by: T. O. Pertseva, et al.
Published: (2018-04-01)

Cytokine profile in community-acquired pneumonia in children
by: N. V. Iziurova, et al.
Published: (2022-11-01)

Nonlinear main components of the cytokine profile in children with community-acquired pneumonia
by: N. V. Iziurova, et al.
Published: (2024-01-01)

Comparing the Mean Platelet Volume and the Neutrophil-to-Lymphocyte Ratio in Children With Bacterial Pneumonia Associated With or Without Pleural Empyema
by: Houman Hashemian, et al.
Published: (2023-01-01)

Mycoplasma pneumoniae infection in hospitalized adult patients with community-acquired pneumonia in China
by: Zongxiao Shangguan, et al.
Published: (2014-10-01)

Community-acquired pneumonia in HIV patients
by: I. B. Viktorova, et al.
Published: (2021-05-01)

MULTILOCI SEQUESTERANT STRAINS OF STREPTOCOCCUS PNEUMONIAE ISOLATED FROM ELDERLY PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
by: A. V. Martynova, et al.
Published: (2014-06-01)

Predictors and etiology of healthcare-associated infections in patients with severe community-acquired pneumonia
by: I. A. Ruslyakova, et al.
Published: (2025-02-01)

Comparison between community-acquired pneumonia and post-obstructive pneumonia associated with endobronchial tumors
by: Wenwen Yu, et al.
Published: (2024-11-01)

Unveiling etiology and mortality risks in community-acquired pneumonia: A machine learning approach
by: Alaa Ali, et al.
Published: (2025-07-01)

The Role of Ultrasound in Diagnosing Community-Acquired Pneumonia
by: D. O. Starostin, et al.
Published: (2023-02-01)

Antibiotic Therapy of Severe Community-Acquired Pneumonia
by: O. V. Molchanova, et al.
Published: (2020-05-01)

Fatal Community-Acquired Pneumonia: 18 Years in a Medical Center
by: Ling-Jen Wang, et al.
Published: (2013-02-01)

Immunological aspects of cytomegalovirus infection in community-acquired pneumonia among young adults.
by: K. D. Chichirelo-Konstantynovych, et al.
Published: (2018-04-01)

Korean Guidelines for the Management and Antibiotic Therapy in Adult Patients with Hospital-Acquired Pneumonia
by: Hayoung Choi, et al.
Published: (2025-01-01)

Modern approaches at the management of children with community-acquired pneumonia
by: Aleksander A. Baranov, et al.
Published: (2023-03-01)

Bacterial and viral etiology in hospitalized community acquired pneumonia with molecular methods and clinical evaluation
by: Derya Çağlayan Serin, et al.
Published: (2014-04-01)

Effectiveness of Cephalosporins /Siderophore Cephalosporins Versus Meropenem as Therapy in Patients with Hospital Acquired Pneumonia
by: Palevi Ruflianasari, et al.
Published: (2025-01-01)

Neutrophils are involved in the development and outcomes of plastic bronchitis associated with Mycoplasma pneumoniae pneumonia
by: Xia Huang, et al.
Published: (2025-03-01)

Role of Inflammatory Markers as a Risk Factor for Community-Acquired Pneumonia Management
by: Ruta Nutautiene, et al.
Published: (2025-06-01)

Problems of assessing the severity of the state of elderly patients with community-acquired pneumonia caused by Klebsiella pneumoniae
by: V. I. Sakharov, et al.
Published: (2020-12-01)

Characterization of the oxidative metabolism of erythrocytes in patients with community-acquired pneumonia
by: L. A. Demidchik, et al.
Published: (2016-05-01)

Epidemiological parallels of community-acquired pneumonia, influenza and ARVI in Moscow
by: T. S. Saltykova, et al.
Published: (2020-04-01)